Predictors of decline in kidney function in the general population: a decade of follow-up from the Tehran Lipid and Glucose Study

被引:6
|
作者
Masrouri, Soroush [1 ]
Alijanzadeh, Dorsa [1 ]
Amiri, Mina [2 ]
Azizi, Fereidoun [3 ]
Hadaegh, Farzad [1 ,4 ]
机构
[1] Shahid Beheshti Univ Med Sci, Res Inst Endocrine Sci, Prevent Metab Disorders Res Ctr, Tehran, Iran
[2] Shahid Beheshti Univ Med Sci, Res Inst Endocrine Sci, Reprod Endocrinol Res Ctr, Tehran, Iran
[3] Shahid Beheshti Univ Med Sci, Res Inst Endocrine Sci, Endocrine Res Ctr, Tehran, Iran
[4] Shahid Beheshti Univ Med Sci, Res Inst Endocrine Sci, Prevent Metab Disorders Res Ctr, 24 Yamen St, Tehran, Iran
关键词
eGFR decline; gender differences; kidney disease progression; risk factors; Tehran Lipid and Glucose Study; GLOMERULAR-FILTRATION-RATE; BLOOD-PRESSURE CONTROL; RENAL-FUNCTION DECLINE; RISK-FACTORS; MEDICATION ADHERENCE; PHYSICAL-ACTIVITY; DISEASE; PROGRESSION; OUTCOMES; GENDER;
D O I
10.1080/07853890.2023.2216020
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background and aims We aimed to assess the potential socio-demographic, clinical, and lifestyle-related risk factors for kidney function decline (KFD), defined as >= 30% estimated glomerular filtration rate (eGFR) decline, in an Iranian cohort study. Methods 7190 participants (4049 women) aged 20-90 years with 2-5 eGFR data from examinations (2001-2005 to 2015-2018) were included. Cox proportional hazard models were used to examine the association between potential risk factors and eGFR decline. Results During 11.5 years of follow-up, 1471 (889 women) participants had incident KFD with a crude incidence rate of 192.1 (182.6-202.2) per 10,000 person-year. Among the total population, older age, female gender, prehypertension, hypertension, diabetes, widowed/divorced states, higher triglycerides (TG), prevalent cardiovascular diseases (CVD), and higher baseline eGFR were significantly associated with higher, while moderate physical activity and a positive family history of diabetes were associated with lower risk of KFD (all p values <.05). Prevalent CVD in women but not men, diabetes, and hypertension among postmenopausal than premenopausal women were significant risk factors of KFD. According to the presence of chronic kidney disease (CKD) at baseline, higher eGFR decreased the risk of KFD in patients with CKD and increased KFD risk in those without CKD (all p for interactions <.05). Conclusion KFD is associated with multiple modifiable risk factors among the Iranian urban population that is affected by gender, menopausal status, and initial kidney function. Interventions targeting these factors might potentially help reduce the burden of KFD. Key messages: Menopausal status may influence the relationship between cardiometabolic risk factors and KFD; The impact of higher baseline eGFR on the risk of KFD differed between subjects with preserved kidney function and CKD patients. The interaction between gender, menopausal status, and baseline kidney function with different risk factors on KFD may help to make renal risk prediction scores to identify those in the general population at risk who may benefit from early prevention.
引用
收藏
页数:14
相关论文
共 50 条
  • [1] Kidney function decline is associated with mortality events: over a decade of follow-up from Tehran Lipid and Glucose Study
    Masrouri, Soroush
    Zadeh, Seyed Saeed Tamehri
    Pishgahi, Mehdi
    Azizi, Fereidoun
    Shapiro, Michael D.
    Hadaegh, Farzad
    JOURNAL OF NEPHROLOGY, 2024, 37 (01) : 107 - 118
  • [2] Kidney function decline is associated with mortality events: over a decade of follow-up from Tehran Lipid and Glucose Study
    Soroush Masrouri
    Seyed Saeed Tamehri Zadeh
    Mehdi Pishgahi
    Fereidoun Azizi
    Michael D. Shapiro
    Farzad Hadaegh
    Journal of Nephrology, 2024, 37 : 107 - 118
  • [3] Cardiovascular risk in different obesity phenotypes over a decade follow-up: Tehran Lipid and Glucose Study
    Mirzaei, Bita
    Abdi, Hengameh
    Serahati, Sara
    Barzin, Maryam
    Niroomand, Mahtab
    Azizi, Fereidoun
    Hosseinpanah, Farhad
    ATHEROSCLEROSIS, 2017, 258 : 65 - 71
  • [4] The association of ideal cardiovascular health metrics and incident hypertension among an urban population of Iran: a decade follow-up in Tehran Lipid and Glucose Study
    Rahmani, Fatemeh
    Asgari, Samaneh
    Azizi, Fereidoun
    Hadaegh, Farzad
    JOURNAL OF HUMAN HYPERTENSION, 2024, 38 (03) : 267 - 276
  • [5] Sudden cardiac death among Iranian population: a two decades follow-up of Tehran lipid and glucose study
    Toreyhi, Hossein
    Asgari, Samaneh
    Khalili, Davood
    Pishgahi, Mehdi
    Azizi, Fereidoun
    Hadaegh, Farzad
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [6] Age and aging effects on blood pressure: 15 years follow-up of Tehran lipid and glucose study
    Khajavi, Alireza
    Zayeri, Farid
    Ramezankhani, Azra
    Nazari, Amir
    Azizi, Fereidoun
    Hadaegh, Farzad
    JOURNAL OF CLINICAL HYPERTENSION, 2021, 23 (06) : 1205 - 1211
  • [7] Abdominal obesity phenotypes and risk of kidney function decline: Tehran Lipid and Glucose Study
    Shahali, Asharf
    Tasdighi, Erfan
    Barzin, Maryam
    Mahdavi, Maryam
    Valizadeh, Majid
    Niroomand, Mahtab
    Azizi, Fereidoun
    Hosseinpanah, Farhad
    OBESITY RESEARCH & CLINICAL PRACTICE, 2020, 14 (02) : 168 - 175
  • [8] Follow-up of women with gestational diabetes in the Tehran Lipid and Glucose Study (TLGS): A population-based cohort study
    Tehrani, Fahimeh Ramezani
    Hashemi, Somayeh
    Hasheminia, Mitra
    Azizi, Freidoon
    JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH, 2012, 38 (04) : 698 - 704
  • [9] The impact of triglyceride-glucose index on incident cardiovascular events during 16 years of follow-up: Tehran Lipid and Glucose Study
    Barzegar, Niloofar
    Tohidi, Maryam
    Hasheminia, Mitra
    Azizi, Fereidoun
    Hadaegh, Farzad
    CARDIOVASCULAR DIABETOLOGY, 2020, 19 (01)
  • [10] Impact of hip circumference and height on incident diabetes: results from 6-year follow-up in the Tehran Lipid and Glucose Study
    Bozorgmanesh, M.
    Hadaegh, F.
    Zabetian, A.
    Azizi, F.
    DIABETIC MEDICINE, 2011, 28 (11) : 1330 - 1336